Soleus Private Equity Fund III, L.P. - 01 Apr 2026 SCHEDULE 13G Report for Aprea Therapeutics, Inc. Common Stock (APRE)
- Filing Manager
- Soleus Private Equity Fund III, L.P.
- Reporting Manager
- Soleus Private Equity Fund III, L.P.
- Symbol
- APRE
- Shares outstanding
- 12,723,524 shares
- Disclosed Ownership
- 1,271,080 shares
- Ownership
- 10%
- Form type
- SCHEDULE 13G
- Filing time
- 01 Apr 2026, 17:00:15 UTC
- Date of event
- 01 Apr 2026
- SEC
- View on sec.gov
Reporting Managers (9)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Soleus Private Equity Fund III, L.P. | 10% | 1,271,080 | 0 | 1,271,080 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus Private Equity GP III, LLC | 10% | 1,271,080 | 0 | 1,271,080 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus PE GP III, LLC | 10% | 1,271,080 | 0 | 1,271,080 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus Capital Master Fund, L.P. | 10% | 1,271,080 | 0 | 1,271,080 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus Capital, LLC | 10% | 1,271,080 | 0 | 1,271,080 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus Capital Group, LLC | 10% | 1,271,080 | 0 | 1,271,080 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus Capital Management, L.P. | 10% | 1,271,080 | 0 | 1,271,080 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Soleus GP, LLC | 10% | 1,271,080 | 0 | 1,271,080 | /s/ Guy Levy | Guy Levy/Managing Member | |
| Guy Levy | 10% | 1,271,080 | 0 | 1,271,080 | /s/ Guy Levy | Guy Levy |